Co-Diagnostics, Inc. (CODX)
USD 0.33
(2.17%)
USD 0.33
(2.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.92 Million USD | 47.29% |
| 2022 | -22.62 Million USD | 74.46% |
| 2021 | -88.6 Million USD | -106.17% |
| 2020 | -42.97 Million USD | -4711.88% |
| 2019 | -893.13 Thousand USD | -193.2% |
| 2018 | 958.33 Thousand USD | 127.11% |
| 2017 | -3.53 Million USD | -247.56% |
| 2016 | 2.39 Million USD | 144.99% |
| 2015 | 977.72 Thousand USD | 555.93% |
| 2014 | -214.44 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -20.3 Million USD | -70.28% |
| 2024 Q2 | -11.27 Million USD | 44.47% |
| 2023 Q3 | -7.19 Million USD | 32.12% |
| 2023 Q1 | -5.42 Million USD | 76.03% |
| 2023 FY | -11.92 Million USD | 47.29% |
| 2023 Q2 | -10.6 Million USD | -95.43% |
| 2023 Q4 | -11.92 Million USD | -65.76% |
| 2022 Q2 | -85.55 Million USD | 11.67% |
| 2022 FY | -22.62 Million USD | 74.46% |
| 2022 Q1 | -96.86 Million USD | -9.32% |
| 2022 Q4 | -22.62 Million USD | 72.1% |
| 2022 Q3 | -81.08 Million USD | 5.22% |
| 2021 Q3 | -82.65 Million USD | -17.62% |
| 2021 FY | -88.6 Million USD | -106.17% |
| 2021 Q1 | -57.78 Million USD | -34.47% |
| 2021 Q2 | -70.27 Million USD | -21.6% |
| 2021 Q4 | -88.6 Million USD | -7.2% |
| 2020 FY | -42.97 Million USD | -4711.88% |
| 2020 Q1 | -17.36 Million USD | -1844.75% |
| 2020 Q2 | -18.55 Million USD | -6.8% |
| 2020 Q3 | -21.23 Million USD | -14.45% |
| 2020 Q4 | -42.97 Million USD | -102.43% |
| 2019 Q4 | -893.13 Thousand USD | 64.89% |
| 2019 FY | -893.13 Thousand USD | -193.2% |
| 2019 Q3 | -2.54 Million USD | 34.02% |
| 2019 Q2 | -3.85 Million USD | 28.76% |
| 2019 Q1 | -5.41 Million USD | -664.79% |
| 2018 Q2 | -1.52 Million USD | 39.86% |
| 2018 FY | 958.33 Thousand USD | 127.11% |
| 2018 Q3 | -307.55 Thousand USD | 79.88% |
| 2018 Q4 | 958.33 Thousand USD | 411.6% |
| 2018 Q1 | -2.54 Million USD | 28.1% |
| 2017 FY | -3.53 Million USD | -247.56% |
| 2017 Q4 | -3.53 Million USD | 23.58% |
| 2017 Q2 | 3.31 Million USD | 14.55% |
| 2017 Q1 | 2.89 Million USD | 20.99% |
| 2017 Q3 | -4.62 Million USD | -239.33% |
| 2016 Q3 | 1.75 Million USD | 0.0% |
| 2016 Q4 | 2.39 Million USD | 36.5% |
| 2016 FY | 2.39 Million USD | 144.99% |
| 2016 Q1 | 33.8 Thousand USD | -96.54% |
| 2015 Q4 | 977.72 Thousand USD | 0.0% |
| 2015 FY | 977.72 Thousand USD | 555.93% |
| 2014 FY | -214.44 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 144.038% |
| BrainsWay Ltd. | -10.32 Million USD | -15.565% |
| Cerus Corporation | 84.35 Million USD | 114.139% |
| Envoy Medical, Inc. | -3.81 Million USD | -212.698% |
| electroCore, Inc. | -9.95 Million USD | -19.802% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -132.709% |
| IceCure Medical Ltd | -9.93 Million USD | -20.055% |
| Inogen, Inc. | -103.56 Million USD | 88.485% |
| OrthoPediatrics Corp. | -9.26 Million USD | -28.697% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -227.556% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 8.939% |
| MaxCyte, Inc. | -27.76 Million USD | 57.042% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -132.116% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1971.378% |
| Orthofix Medical Inc. | 96.44 Million USD | 112.366% |
| PAVmed Inc | 29.08 Million USD | 141.004% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 29.593% |
| RxSight, Inc. | -6.68 Million USD | -78.538% |
| Sight Sciences, Inc. | -102.71 Million USD | 88.389% |
| SI-BONE, Inc. | 5.72 Million USD | 308.465% |
| TELA Bio, Inc. | -3.94 Million USD | -202.008% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 120.806% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 3488.157% |
| Acutus Medical, Inc. | 12.27 Million USD | 197.128% |
| Talis Biomedical Corporation | -57.06 Million USD | 79.1% |
| Spectral AI, Inc. | -3.5 Million USD | -240.654% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 75.167% |
| CVRx, Inc. | -59.95 Million USD | 80.108% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 701.081% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1033.466% |
| Bioventus Inc. | 372.51 Million USD | 103.202% |
| Venus Concept Inc. | 74.3 Million USD | 116.051% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -17.131% |
| LivaNova PLC | 62.53 Million USD | 119.072% |
| 908 Devices Inc. | -115.09 Million USD | 89.638% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 103.719% |
| Nemaura Medical Inc. | 9.92 Million USD | 220.164% |
| NeuroPace, Inc. | 54.33 Million USD | 121.949% |
| LENSAR, Inc. | -18.31 Million USD | 34.872% |
| Apyx Medical Corporation | -5.15 Million USD | -131.534% |
| Cutera, Inc. | 288.3 Million USD | 104.137% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 258.7% |
| BioSig Technologies, Inc. | 262 Thousand USD | 4652.027% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 72.79% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -29.648% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.849% |
| Axonics, Inc. | -77.19 Million USD | 84.55% |
| Outset Medical, Inc. | 67.67 Million USD | 117.622% |
| IRIDEX Corporation | -4.28 Million USD | -178.132% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 93.301% |
| IRadimed Corporation | -47.71 Million USD | 75.007% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -294.128% |
| INVO Bioscience, Inc. | 8.45 Million USD | 241.121% |
| Telesis Bio, Inc. | 32.63 Million USD | 136.545% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -376.646% |
| Varex Imaging Corporation | 316.9 Million USD | 103.763% |
| Quipt Home Medical Corp. | 81.73 Million USD | 114.592% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -328.696% |
| Pulmonx Corporation | -42.36 Million USD | 71.845% |
| Dynatronics Corporation | 6.2 Million USD | 292.235% |
| Modular Medical, Inc. | -8.04 Million USD | -48.3% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -177.55% |
| Semler Scientific, Inc. | -57.13 Million USD | 79.124% |
| InMode Ltd. | -135.39 Million USD | 91.191% |
| Bruker Corporation | 891.3 Million USD | 101.338% |
| Cytosorbents Corporation | 4.18 Million USD | 385.181% |
| DexCom, Inc. | 2.02 Billion USD | 100.588% |
| Align Technology, Inc. | -840.47 Million USD | 98.581% |
| Viveve Medical, Inc. | -13.81 Million USD | 13.659% |
| ZimVie Inc. | 450.41 Million USD | 102.648% |
| Movano Inc. | -5.86 Million USD | -103.312% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 91.13% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1971.378% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 701.081% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 103.343% |
| Profound Medical Corp. | -18.17 Million USD | 34.393% |
| Insulet Corporation | 798.1 Million USD | 101.494% |
| enVVeno Medical Corporation | -2.21 Million USD | -437.706% |
| Surmodics, Inc. | -12.01 Million USD | 0.73% |
| iCAD, Inc. | -21.2 Million USD | 43.768% |
| Nuwellis, Inc. | -2.81 Million USD | -323.069% |
| Biotricity, Inc. | 23.09 Million USD | 151.645% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 112.735% |
| Aethlon Medical, Inc. | -4.5 Million USD | -164.931% |
| InspireMD, Inc. | -8.04 Million USD | -48.245% |
| PAVmed Inc. | 29.08 Million USD | 141.004% |
| BIOLASE, Inc. | 11.34 Million USD | 205.133% |
| Beyond Air, Inc. | 6.22 Million USD | 291.464% |
| FONAR Corporation | -14.66 Million USD | 18.677% |
| AxoGen, Inc. | 32.26 Million USD | 136.962% |
| Vivani Medical, Inc. | 42 Thousand USD | 28495.979% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -11.9% |
| Inari Medical, Inc. | -7.16 Million USD | -66.545% |
| UFP Technologies, Inc. | 40.77 Million USD | 129.25% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 488.653% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -149.959% |
| Tenon Medical, Inc. | -1.25 Million USD | -850.304% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -56.801% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.538% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1417.824% |
| NanoVibronix, Inc. | -3.27 Million USD | -263.829% |
| Quanterix Corporation | -132.95 Million USD | 91.03% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -328.696% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 46.674% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.582% |
| TransMedics Group, Inc. | 121.13 Million USD | 109.846% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 54.445% |
| NeuroMetrix, Inc. | -1.49 Million USD | -699.849% |
| Hyperfine, Inc. | -75.61 Million USD | 84.228% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 107.837% |
| Biomerica, Inc. | -3.38 Million USD | -252.328% |
| Bone Biologics Corporation | -3.02 Million USD | -294.054% |
| AVITA Medical, Inc. | -26.23 Million USD | 54.535% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -548.729% |
| Silk Road Medical, Inc | 64.42 Million USD | 118.513% |